Assetmark, Inc Neurocrine Biosciences Inc Transaction History

Assetmark, Inc

$34.9 Billion
Q3 2024

A detailed history of Assetmark, Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Assetmark, Inc holds 18,323 shares of NBIX stock, worth $2.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

18,323

Previous 16,570 10.58%

Holding current value

$2.5 Million

Previous $2.28 Million 7.54%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$114.58 - $153.15 $200,858 - $268,471	1,753 Added 10.58%	18,323 $2.11 Million
Q2 2024 Aug 13, 2024	BUY	$130.86 - $143.19 $583,635 - $638,627	4,460 Added 36.83%	16,570 $2.28 Million
Q1 2024 May 06, 2024	SELL	$130.4 - $143.74 $3.24 Million - $3.57 Million	-24,845 Reduced 67.23%	12,110 $1.67 Million
Q4 2023 Feb 09, 2024	BUY	$106.07 - $132.76 $920,475 - $1.15 Million	8,678 Added 30.69%	36,955 $4.87 Million
Q3 2023 Oct 27, 2023	BUY	$94.02 - $117.1 $408,987 - $509,385	4,350 Added 18.18%	28,277 $3.18 Million
Q2 2023 Aug 11, 2023	BUY	$89.53 - $104.87 $371,639 - $435,315	4,151 Added 20.99%	23,927 $2.26 Million
Q1 2023 May 05, 2023	BUY	$94.11 - $123.02 $179,091 - $234,107	1,903 Added 10.65%	19,776 $2 Million
Q4 2022 Feb 10, 2023	BUY	$106.72 - $127.06 $156,985 - $186,905	1,471 Added 8.97%	17,873 $2.13 Million
Q3 2022 Nov 01, 2022	BUY	$92.03 - $107.81 $269,555 - $315,775	2,929 Added 21.74%	16,402 $1.74 Million
Q2 2022 Aug 03, 2022	BUY	$75.79 - $100.07 $327,185 - $432,002	4,317 Added 47.15%	13,473 $1.31 Million
Q1 2022 May 13, 2022	BUY	$72.45 - $94.81 $296,537 - $388,057	4,093 Added 80.84%	9,156 $858,000
Q4 2021 Feb 14, 2022	BUY	$79.65 - $106.22 $285,545 - $380,798	3,585 Added 242.56%	5,063 $431,000
Q3 2021 Nov 12, 2021	BUY	$86.18 - $99.03 $127,374 - $146,366	1,478 New	1,478 $142,000
Q3 2019 Nov 13, 2019	SELL	$83.82 - $101.5 $1,005 - $1,218	-12 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$72.24 - $91.27 $144 - $182	2 Added 20.0%	12 $1,000
Q1 2019 May 14, 2019	SELL	$69.31 - $91.53 $1,247 - $1,647	-18 Reduced 64.29%	10 $1,000
Q4 2018 Feb 13, 2019	BUY	$68.32 - $124.36 $1,912 - $3,482	28 New	28 $2,000
Q1 2018 May 16, 2018	SELL	$75.88 - $92.43 $1,517 - $1,848	-20 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$58.53 - $77.59 $877 - $1,163	15 Added 300.0%	20 $2,000
Q3 2017 Nov 08, 2017	SELL	$47.97 - $61.28 $479 - $612	-10 Reduced 66.67%	5 $0
Q4 2015 Sep 15, 2017	BUY	N/A	15	15 $1,000

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account